Altogether, the knowledge acquired from structural and functional studies using the recently discovered KV4/KChIPs modulators and those likely to come soon will help understand the underlying mechanism involving KV4-mediated-channelopathies, establishing the foundations for drug discovery, and hence their treatments. Here, KCNC1 is linked to channelopathy.